Riveme^®

Therapeutic Segment:
Anti-cholinesterases

Generic Name:
Rivastigmine Tartrate

Description:
Rivastigmine tartrate is a reversible cholinesterase inhibitor and is known chemically as (S)-N-Ethyl-Nmethyl- 3-[1-(dimethylamino) ethyl]-phenyl carbamate hydrogen-(2R,3R)-tartrate.

Indication:
RIVASTIGMINE is indicated for the treatment of mild-to-moderate dementia of the Alzheimer’s type (AD) & mild-to-moderate dementia associated with Parkinson’s disease (PD).

Formulation:

• Capsules
• Oral Solution

Strength:

• Capsules: 1.5mg, 3mg
• Oral Solution: 2mg/ml

Pack Size:

• Capsules: 60’s, 60’s
• Oral Solution: 60ml